| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Culley Brian M is a President And CEO at LCTX. Recent filings cover 6 purchases and 1 sale. Those positions are worth an estimated $281K at current prices.
Our model assigns Culley Brian M a middling insider score of 56/100, based on 6 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of +22.3%.
Culley Brian M's largest disclosed position is in LCTX as President And CEO, worth about $281K. The recent filings there lean toward selling, a net 363,350 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 15,000 | $1.63 | $24,375.00 | +6.2% | -22.2% | - | |
| Nov 21, 2024 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 40,000 | $0.60 | $24,000.00 | +25.8% | +19.8% | +190.0% | |
| May 24, 2024 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 10,000 | $1.05 | $10,500.00 | +6.9% | -15.0% | -35.0% | |
| Mar 31, 2022 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 6,400 | $1.53 | $9,792.00 | +7.0% | +4.5% | -2.6% | |
| Mar 25, 2022 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 5,250 | $1.38 | $7,245.00 | +6.9% | -8.8% | -1.4% | |
| Jun 28, 2021 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Sale+OE | 450,000 | $2.87 | $1,291,500.00 | -90.8% | -7.6% | -50.5% | |
| Aug 13, 2019 | LCTX Lineage Cell Therapeutics, Inc. | President And CEO | Buy | 10,000 | $1.01 | $10,100.00 | +13.4% | - | - |